COLL compared with ANDE: revenue, margins and what each company keeps, and the suppliers and customers both name

COLLCollegium Pharmaceutical, Inc

Mkt capRevenueRevenue

ANDEAndersons, Inc.

Mkt capRevenueRevenue

Compare

COLLCollegium Pharmaceutical, Inc

ANDEAndersons, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

COLL

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±12.2%▼−18.55%×1.52

May 7 '26±12.6%▲+7.72%×0.61

Q1 FY26±7.7%▼−3.34%×0.43

Q3 FY25±9.4%▲+13.42%×1.43

ANDE

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±8.1%▲+6.61%×0.81

Q1 FY26±7.1%▼−13.95%×1.96

= impliedCOLL realized, solidANDE realized, hatchedOne scale, both sides: full bar = 19%× = |realized| ÷ impliedSource: market data

Feb 18 '26

±6.2%

▼−3.54%

×0.56

Nov 5 '25±10.4%▲+4.46%×0.43

COLLCollegium Pharmaceutical, Inc

23.71▼−0.38%· post 23.71· delayed

Mkt cap$774.8MRevenue$200MQ2 FY26Revenue$781MFY25

ANDEAndersons, Inc.

63.75▼−0.84%· post 63.89· delayed

After hoursNov 2 '26delayed

Mkt cap$2.2BRevenue$3.1BQ2 FY26Revenue$11.0BFY25

Compare

After hoursNov 2 '26delayed

COLLCollegium Pharmaceutical, Inc

ANDEAndersons, Inc.

23.71▼−0.38%post 23.71delayed

Price

63.75▼−0.84%post 63.89delayed

$774.8M

Mkt cap

$2.2B

Q2 FY26$200M

Revenue

$3.1BQ2 FY26

FY25$781M

Revenue

$11.0BFY25

COLL23.71▼−0.38%vsANDE63.75▼−0.84%After hoursNov 2 '26delayed